Download our immuno-oncology white paper

Are you conducting an immuno-oncology clinical trial? 

With the field of immuno-oncology constantly changing as a result of advances in cancer biology and immunology research, an understanding of clinical biomarker testing is needed now more than ever. In this complimentary white paper, learn about the importance of diverse clinical biomarker testing and the challenges diverse clinical biomarker requirements face in in these trials.

Also in this whitepaper, learn how Q2 Solutions is bringing 3 key research tools, including anatomic pathology, flow cytometry, and genomics into immuno-oncology clinical trials in order to drive successful immuno-oncology studies for biopharma sponsors.

Meet the authors:
  • Linda Robbie, Ph.D, Senior Director, Biomarkers and Global Translational Science Laboratory
  • Radha Krishnan, M.D., Chief Pathologist and Senior Medical Director
  • Patrick Hurban, Ph.D., Senior Director and Global Head, Translational Genomics
  • Alistair J. Watt, Ph.D., Director, Translational Science Laboratory, Europe
Anatomic Pathology brochure

Comprehensive in-house end-to-end anatomic pathology and adjunct molecular services

Global Flow Cytometry Services

Unique global flow cytometry services implemented with customizable solutions are designed to meet your clinical trial needs

Q2 Solutions Biomarker Services

Providing tools and experience to maximize your biomarker strategy

Read More